Crossmark

Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy

Crossref DOI link: https://doi.org/10.1007/s11605-019-04161-9

Published Print: 2020-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chevrollier, Guillaume S.

Giugliano, Danica N.

Palazzo, Francesco

Keith, Scott W.

Rosato, Ernest L.

Evans III, Nathaniel R.

Berger, Adam C.
License Information

Text and Data Mining valid from 2020-02-01

Text and Data Mining valid from 2020-02-01
More Information

This article is maintained by: Elsevier

Article Title: Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy

Journal Title: Journal of Gastrointestinal Surgery

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s11605-019-04161-9

Content Type: article

Copyright: Copyright © 2019 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.

Document is current

Any future updates will be listed below